Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancerYoung‐Won Cho(Seoul National University of Science and Technology), Tae‐You Kim(Seoul National University of Science and Technology)Molecular OncologyNovember 30, 202110.1002/1878-0261.13144Cited by 43SaveCiteExport RISWatch citationsRelated Papers<scp>FGFR</scp>2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers <i>in vitro</i>|Molecular Oncology|2018|33Identifying TP53RK as a key regulator of colorectal cancer survival and a potential therapeutic target|Scientific Reports|2025|1